Hormone Receptor Expression in Primary and Recurrent High-Grade Serous Ovarian Cancer and Its Implications in Early Maintenance Treatment

Endocrine therapy is an effective treatment for low-grade serous ovarian cancer. However, the role of estrogen and progesterone receptors as biomarkers for high-grade serous ovarian cancer (HGSOC) is yet to be elucidated because not all estrogen and progesterone receptor-positive tumors benefit from...

Descripción completa

Detalles Bibliográficos
Autores principales: Vetter, Marcus, Stadlmann, Sylvia, Bischof, Evelyne, Georgescu Margarint, Elena Laura, Schötzau, Andreas, Singer, Gad, Heinzelmann-Schwarz, Viola, Montavon, Céline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692716/
https://www.ncbi.nlm.nih.gov/pubmed/36430718
http://dx.doi.org/10.3390/ijms232214242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692716/
https://www.ncbi.nlm.nih.gov/pubmed/36430718
http://dx.doi.org/10.3390/ijms232214242

Ejemplares similares